PRC
DCPH

Pearl River Capital’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Pearl River Capital’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,177
Closed -$238K – 548
2020
Q4 		$238K Sell
4,177
-574
-12% -$34K 0.09% 312
2020
Q3 		$244K Buy
+4,751
New +$233K 0.1% 302
2019
Q1 		– Sell
-131
Closed -$3K – 868
2018
Q4 		$3K Buy
+131
New +$3.22K 0.01% 776

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pearl River Capital's DCPH Position: Q1 2021 in Review

Pearl River Capital sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2021, closing a stake of 4,177 shares — an estimated $238K sold.

Pearl River Capital first reported a position in DCPH in Q4 2018 and held it in 3 quarters. The position peaked at $244K in Q3 2020. 167 funds tracked by Wall St. Rank hold DCPH as of Q1 2021.

  • Pearl River Capital reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Pearl River Capital sold 4,177 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2021, an estimated $238K.
  • Pearl River Capital first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 3 quarters.
  • Pearl River Capital's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $244K in Q3 2020.
  • 167 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2021.

Based on Pearl River Capital's 13F filing for Q1 2021, filed 14 May 2021.